1. Home
  2. EHLD vs IXHL Comparison

EHLD vs IXHL Comparison

Compare EHLD & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHLD
  • IXHL
  • Stock Information
  • Founded
  • EHLD 2024
  • IXHL 2001
  • Country
  • EHLD Greece
  • IXHL Australia
  • Employees
  • EHLD N/A
  • IXHL N/A
  • Industry
  • EHLD
  • IXHL
  • Sector
  • EHLD
  • IXHL
  • Exchange
  • EHLD NYSE
  • IXHL Nasdaq
  • Market Cap
  • EHLD 17.2M
  • IXHL 20.5M
  • IPO Year
  • EHLD N/A
  • IXHL N/A
  • Fundamental
  • Price
  • EHLD $7.75
  • IXHL $0.20
  • Analyst Decision
  • EHLD
  • IXHL
  • Analyst Count
  • EHLD 0
  • IXHL 0
  • Target Price
  • EHLD N/A
  • IXHL N/A
  • AVG Volume (30 Days)
  • EHLD 51.1K
  • IXHL 36.3M
  • Earning Date
  • EHLD 06-25-2025
  • IXHL 05-15-2025
  • Dividend Yield
  • EHLD N/A
  • IXHL N/A
  • EPS Growth
  • EHLD N/A
  • IXHL N/A
  • EPS
  • EHLD N/A
  • IXHL N/A
  • Revenue
  • EHLD $15,640,631.00
  • IXHL $98,000.00
  • Revenue This Year
  • EHLD N/A
  • IXHL $3,817.06
  • Revenue Next Year
  • EHLD N/A
  • IXHL $66.67
  • P/E Ratio
  • EHLD $5.75
  • IXHL N/A
  • Revenue Growth
  • EHLD N/A
  • IXHL N/A
  • 52 Week Low
  • EHLD $3.83
  • IXHL $0.08
  • 52 Week High
  • EHLD $12.80
  • IXHL $3.13
  • Technical
  • Relative Strength Index (RSI)
  • EHLD N/A
  • IXHL 45.47
  • Support Level
  • EHLD N/A
  • IXHL $0.20
  • Resistance Level
  • EHLD N/A
  • IXHL $0.23
  • Average True Range (ATR)
  • EHLD 0.00
  • IXHL 0.02
  • MACD
  • EHLD 0.00
  • IXHL 0.01
  • Stochastic Oscillator
  • EHLD 0.00
  • IXHL 33.30

About EHLD EUROHOLDINGS LTD

Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: